Eton Pharmaceuticals, Inc.·4

Feb 28, 4:32 PM ET

Troutman William Wilson 4

4 · Eton Pharmaceuticals, Inc. · Filed Feb 28, 2022

Insider Transaction Report

Form 4
Period: 2022-02-07
Troutman William Wilson
CFO, Treasurer & Secretary
Transactions
  • Award

    Stock Option (Right to buy)

    2022-02-07+15,000671,200 total
    Exercise: $3.78Exp: 2032-02-07Common Stock (15,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on February 7, 2026.

Documents

1 file
  • 4
    ownership.xmlPrimary